Screener
Protagonist Therapeutics PTGX Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Protagonist Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The source filing: Protagonist Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091123
FAQ
- What is Protagonist Therapeutics's total liabilities?
- Protagonist Therapeutics (PTGX) reported total liabilities of $44M in Q2 2026.
- How has Protagonist Therapeutics's total liabilities changed year-over-year?
- Protagonist Therapeutics's total liabilities decreased by 12.0% year-over-year, from $49.99M to $44M.
- What is the long-term trend for Protagonist Therapeutics's total liabilities?
- Over 5 years (2020 to 2025), Protagonist Therapeutics's total liabilities has grown at a 3.6% compound annual growth rate (CAGR), from $44.86M to $53.48M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.
Ask your AI about Protagonist Therapeutics's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude